Shen, YehuaCheng, Chien-shanWang, PengXu, ZhuLei, GuangyanFang, YongLi, HailiangFan, WeijunPan, HongmingTang, ZheMa, KuanshengLi, XiaoguangZhengyu, LinZhuang, YipingYe, XinBo, ZhaiHan, YueHuang, JinhuaXu, HuixiongZheng, RongqinChen, RufuYu, JieXu, DongWang, ZhongminMeng, Zhiqiang2020-11-182020-11-182020-05Shen Yehua, Cheng Chien-shan, Wang Peng, Xu Zhu, Lei Guangyan, Fang Yong, Li Hailiang, Fan Weijun, Pan Hongming, Tang Zhe, Ma Kuansheng, Li Xiaoguang, Zhengyu Lin, Zhuang Yiping, Ye Xin, Bo Zhai, Han Yue, Huang Jinhua, Xu Huixiong, Zheng Rongqin, Chen Rufu, Yu Jie, Xu Dong, Wang Zhongmin, Meng Zhiqiang. CSCO ablation expert workshop report: Recommendations for the management of tumor ablation during the coronavirus disease 2019 epidemic. Journal of Cancer Research and Therapeutics. 2020 May; 16(2): 350-3550973-1482http://imsear.searo.who.int/handle/123456789/213824The coronavirus disease 2019 (COVID-19) has become a global pandemic since its outbreak in December 2019, which posed a threat to the safety and well-being of people on a global scale. Cancer patients are at high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and their critical morbidity and case fatality rates are high. The ablation expert committee of the Chinese Society of Clinical Oncology compiled corresponding expert recommendations. These recommendations summarize the preventive measures and management of tumor ablation treatment in medical institutions, including outpatient clinics, oncology wards, ablation operation room, and postablation follow-ups in accordance with the guidelines and protocols imposed by the National Health Commission of the People's Republic of China and the experience in management and prevention according to various hospitals. This consensus aims to reduce and prevent the spread of SARS-CoV-2 and its cross-infection between cancer patients in hospitals and provide regulatory advice and guidelines for medical personnelAblation therapycoronavirus disease 2019tumorCSCO ablation expert workshop report: Recommendations for the management of tumor ablation during the coronavirus disease 2019 epidemicJournal ArticleIndiaMinimally Invasive Therapy Center, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaMinimally Invasive Therapy Center, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Interventional Therapy, Peking University Cancer Hospital & Institute, Beijing, ChinaDepartment of Thoracic Surgery, Shaanxi Provincial Tumor Hospital, Xi'an, ChinaDepartment of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Minimal-Invasive Intervention, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Minimally Invasive Interventional Center, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, ChinaDepartment of Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, ChinaInstitute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, ChinaDepartment of Center of Minimally Invasive Therapies for Tumors, Beijing Hospital, National Center of Gerontology, Beijing, ChinaDepartment of Interventional Radiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Interventional Therapy, Jiangsu Cancer Hospital, Nanjing, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University, Jinan, ChinaDepartment of Interventional Oncology, Renji Hospital, School of Medicine, Jiaotong University, Shanghai, ChinaDepartment of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Medical Ultrasound, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Tongji University, Cancer Center, Shanghai Engineering Research Center of Ultrasound Diagnosis and Treatment, Tongji University School of Medicine, Shanghai, ChinaDepartment of Ultrasound, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, ChinaDepartment of General Surgery, Guangdong Provincial Peoplefs Hospital, Guangdong Academy of Medical Sciences, Guangdong, The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, ChinaDepartment of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, ChinaDepartment of Ultrasound, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, ChinaDepartment of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China